文献速递传染病防控与疫情报告免疫规划

混合免疫对新冠病毒感染的保护优于单纯接种疫苗:基于人群主动监测研究

Hybrid immunity provides stronger protection against SARS-CoV-2 infection than vaccination alone: Evidence from a population-based active monitoring study.
PubMed 文献 · Vaccine · 2026-03-23

本研究基于哥斯达黎加RESPIRA人群队列,比较混合免疫者(感染后接种两剂疫苗)与仅接种两剂疫苗者的唾液PCR检测阳性风险。

要点

  • 混合免疫者较仅接种两剂疫苗者感染风险显著降低(调整OR=0.61)。
  • 研究采用唾液自采样本每月随访,结果与自我报告诊断一致。
  • 既往感染加疫苗接种可增强对SARS-CoV-2感染的保护。

核心结论

  • 混合免疫对SARS-CoV-2感染的保护强于仅接种两剂疫苗。

研究设计与样本

  • 比较混合免疫者(入组前PCR确诊感染且接种两剂疫苗,N=1157份标本)与仅接种两剂疫苗且无既往感染证据者(N=1712份标本)。
  • 所有标本采集于2021年6月至2022年5月,采用GEE模型调整人口学、标本相关及流行病学因素。

主要发现

  • 以自我报告COVID-19诊断作为结局时,结果一致。

临床怎么用

  • 在评估个体感染风险时,可考虑既往感染史与疫苗接种的联合保护作用。
  • 混合免疫者可能具有更强保护,但不应以此替代常规疫苗接种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hybrid immunity, defined as vaccination plus prior infection, induces higher antibody levels than vaccination alone, but there is limited evidence on whether this enhanced immunological response translates into greater real-world protection against SARS-CoV-2 infection, particularly in population-based active-monitoring cohorts. METHODS: We used data from RESPIRA, a population-based longitudinal cohort in Costa Rica that enrolled participants between November 2020 and October 2021 and followed them monthly for two years with guided saliva self-collection. We compared PCR testing results from saliva specimens collected from individuals with hybrid immunity (PCR-confirmed infection before enrollment plus two vaccine doses; N = 1157 specimens) to those from participants with two vaccine doses and no evidence of prior infection (N = 1712 specimens). All selected samples were collected between June 2021 and May 2022. The two groups were compared using GEE models adjusted for demographic, specimen-related and epidemiologic factors. RESULTS: Hybrid immunity was associated with substantially lower risk of SARS-CoV-2 infection measured by PCR in saliva samples compared with vaccination alone (adjusted OR = 0.61 [0.43-0.84]). Findings were consistent when using self-reported COVID-19 diagnosis as the outcome. CONCLUSIONS: Hybrid immunity conferred stronger protection against SARS-CoV-2 infection than two vaccine doses alone.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fantin R, Das S, Loria V, et al. Hybrid immunity provides stronger protection against SARS-CoV-2 infection than vaccination alone: Evidence from a population-based active monitoring study. Vaccine. 2026. PMID: 41875691. doi:10.1016/j.vaccine.2026.128506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。